CVS Health Plans to Split Into Two Public Companies by 2028
CVS Health is reportedly planning to divide into two separate publicly traded companies by 2028, according to the Financial Times.
CVS Health is moving toward breaking itself into two distinct publicly traded entities by 2028, the Financial Times reported, marking a significant strategic reversal for one of the largest healthcare conglomerates in the United States.
The planned separation would restructure a company that has spent years assembling an expansive healthcare empire through major acquisitions, including its roughly $70 billion purchase of insurer Aetna in 2018 and its acquisition of pharmacy benefits manager Caremark. The reported split signals that the integrated model the company championed may no longer be viewed internally as the optimal path forward.
Read more Labubu Collectible Craze Fades as Pop Mart Revenue Drops →
The move reflects broader pressures facing large healthcare companies, which have confronted rising medical costs, shrinking margins in pharmacy retail operations, and intensifying investor scrutiny over sprawling corporate structures that can obscure underlying business performance. Separating distinct business units into standalone companies is widely seen as a way to unlock shareholder value and allow each entity to pursue more focused strategies.
CVS has not been immune to these headwinds. The company has faced earnings pressure and leadership challenges in recent years, prompting investors and analysts to question whether its diversified model delivers sufficient returns relative to its complexity. A formal breakup, if confirmed, would represent one of the most consequential restructurings in the American healthcare sector in recent memory.
Details on how exactly CVS intends to divide its operations — including which businesses would be grouped under each new entity — were not immediately available from the reporting. Continue reading at All News.
